Co-Founder, April19 Discovery Inc
Suran is a co-founder of April19 (www.april19.ai), an AI-driven drug-discovery company focused on novel psychedelic compounds for mood disorders, pain management and addiction cessation. He is also a …
To bring a drug to market used to cost $1B-$2B and 10 years. With AI-driven drug discovery, pre-clinical testing for entirely novel drug candidates can be started within 50 days. We present our work in screening candidate psychedelic drug compounds and the discovery of novel compounds, through the power of AI.
Details
Date: | 11/08/2021 |
Start Time: | 10:30 am |
End Time: | 10:50 |